e-learning
resources
ERJ
2012
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
What the pulmonary specialist should know about the new inhalation therapies
Mitchell J.P.
Source:
Eur Respir J 2012; 39: 1054-1055
Journal Issue:
April
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Mitchell J.P.. What the pulmonary specialist should know about the new inhalation therapies. Eur Respir J 2012; 39: 1054-1055
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
What the pulmonary specialist should know about the new inhalation therapies
Source: Eur Respir J 2011; 37: 1308-1417
Year: 2011
What does the future hold for pulmonary rehabilitation?
Source: Eur Respir Monogr 2021; 93: 311-325
Year: 2021
Pathophysiology of pulmonary hypertension: what the interested clinician needs to know
Source: ERS Course 2020 - Pulmonary hypertension and pulmonary vascular disease
Year: 2020
Improving symptomology in COPD: which therapy would you choose, a brochodilator or pulmonary rehabilitation?
Source: International Congress 2019 – Hot topics in pulmonary rehabilitation
Year: 2019
Goal-oriented therapy in paediatric pulmonary arterial hypertension: are we ready?
Source: Eur Respir J 2014; 44: 1404-1407
Year: 2014
Assessing pulmonary hypertension severity in lung disease is a key step to improving outcomes: embrace resistance and don't be pressurised to go with the flow
Source: Eur Respir J, 58 (2) 2102008; 10.1183/13993003.02008-2021
Year: 2021
Are we ready for home treatment of acute pulmonary embolism?
Source: International Congress 2014 – Current controversies in the management of acute pulmonary embolism
Year: 2014
What happens after pulmonary rehabilitation?
Source: Eur Respir Monogr 2021; 93: 218-230
Year: 2021
Is there room for further innovation in inhaled therapy for airways disease?
Source: Breathe, 14 (3) 216; 10.1183/20734735.020318
Year: 2018
Predicting physician decision to prescribe systemic corticosteroids following an exacerbation of airways disease
Source: International Congress 2019 – Clinical approach to asthma management
Year: 2019
An evidence-based and step-wise approach to treat pulmonary sarcoidosis with old and new drugs
Source: International Congress 2019 – State of the art session: Interstitial lung diseases
Year: 2019
COPD guides and inhaled corticosteroids. Is there an adequate use in primary care?
Source: International Congress 2016 – Targeting care, pulmonary rehabilitation, management, and self-management of COPD exacerbations in primary care
Year: 2016
“I don’t think there’s a simple way of doing it:” the use of an electronic alert to identify excessive prescribing of short-acting beta2-agonists for people with asthma – a qualitative study with asthma experts and primary care staff
Source: Virtual Congress 2020 – Diagnosis and management of airways disease in primary care
Year: 2020
Physicians’ and patients’ expectations of therapies for pulmonary arterial hypertension: where do they meet?
Source: Eur Respir Rev 2014; 23: 458-468
Year: 2014
Expanding the scope of pulmonary rehabilitation
Source: Annual Congress 2005 - The ERS/ATS statements on pulmonary rehabilitation
Year: 2005
The effectiveness of pulmonary rehabilitation including occupational therapy in patients with chronic pulmonary emphysema
Source: Eur Respir J 2002; 20: Suppl. 38, 376s
Year: 2002
Whither pulmonary rehabilitation? Will alternative modes help or hurt?
Source: Eur Respir J, 52 (4) 1801678; 10.1183/13993003.01678-2018
Year: 2018
Repurposing benzbromarone for pulmonary arterial hypertension: can channelling the past deliver the therapy of the future?
Source: Eur Respir J, 53 (6) 1900583; 10.1183/13993003.00583-2019
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept